tiprankstipranks
Noxopharm Partners with CRO for HERACLES Trial
Company Announcements

Noxopharm Partners with CRO for HERACLES Trial

Noxopharm Ltd. (AU:NOX) has released an update.

Don't Miss Our Christmas Offers:

Noxopharm Limited has partnered with a seasoned Australian contract research organization to support its upcoming HERACLES clinical trial, focusing on areas such as drug safety and data management. This collaboration aims to ensure efficient trial execution and reliable data collection, marking a significant step forward for Noxopharm’s innovative cancer and inflammation treatments. The company is also progressing in selecting a Phase 1 unit to further advance the trial.

For further insights into AU:NOX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App